Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
693.00    -9.50 (-1.35%)
Bid:
692.00
Ask:
695.00
Spread: 3.00 (0.434%)
Market Cap: £1.18b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

 

 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least £15m by mid-2027 for a net cash cost of £10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

 

 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

 

15.9%

4.9%

14.9%

 

 

 

Half year to 30 June 2024

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

 

18.0%

5.4%

16.7%

 

 

 

2024 FY

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

 

18.4%

4.7%

17.0%

 

 

 

 

 

 

For further information, please contact:

 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 



Date   Source Headline
25th Mar 20247:00 amPRNTransaction in Own Shares
22nd Mar 20247:00 amPRNTransaction in Own Shares
21st Mar 20242:55 pmPRNDirector/PDMR Shareholding
21st Mar 20242:29 pmPRNDirector/PDMR Shareholding
21st Mar 20247:00 amPRNTransaction in Own Shares
20th Mar 20247:00 amPRNTransaction in Own Shares
19th Mar 202411:24 amPRNDirector/PDMR Shareholding
19th Mar 20247:00 amPRNTransaction in Own Shares
18th Mar 20247:00 amPRNTransaction in Own Shares
15th Mar 20247:10 amRNSLaunch of £60 million Share Buyback Programme
15th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
11th Mar 20247:00 amPRNBoard Change
1st Mar 20249:27 amPRNDirector Declaration
29th Feb 20244:30 pmPRNTotal Voting Rights
31st Jan 20244:30 pmPRNTotal Voting Rights
31st Jan 20243:57 pmPRNBodycote plc - Holding(s) in Company
22nd Jan 20247:00 amRNSAcquisition Update and Share Buyback Programme
8th Jan 20244:37 pmPRNHolding(s) in Company
29th Dec 202312:25 pmPRNTotal Voting Rights
8th Dec 20234:40 pmPRNDirector/PDMR Shareholding
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility
29th Sep 20234:30 pmPRNBodycote plc - Total Voting Rights
31st Aug 20234:30 pmPRNBodycote plc - Total Voting Rights
16th Aug 20232:38 pmPRNDirector/PDMR Shareholding
4th Aug 202310:43 amPRNHolding(s) in Company
31st Jul 20235:00 pmPRNTotal Voting Rights
27th Jul 20237:00 amRNSInterim results for the six months to 30 June 2023
30th Jun 20235:00 pmPRNTotal Voting Rights
31st May 202312:45 pmRNSSenior Independent Director succession
31st May 202312:43 pmRNSResult of AGM
31st May 20237:00 amRNSGroup Chief Executive Succession Process
31st May 20237:00 amRNSTrading Update
28th Apr 20235:02 pmPRNTotal Voting Rights
17th Mar 20237:00 amRNSFull year results for year ended 31 December 2022
16th Mar 20237:00 amRNSRemuneration Committee Chair Succession
18th Nov 20227:00 amRNSTrading Update
31st Oct 20227:00 amRNSAppointment of Chief Financial Officer
29th Jul 20227:00 amRNSInterim results for the six months to 30 June 2022
28th Jun 20229:22 amRNSHolding(s) in Company
31st May 20225:02 pmPRNTotal Voting Rights
27th May 20224:47 pmRNSHolding(s) in Company
27th May 20227:00 amRNSHolding(s) in Company
26th May 20225:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.